Published in Cancer Res on April 15, 1989
The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. Neuro Oncol (2006) 2.53
Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS? J Anat (2004) 1.39
Glypican-1 is frequently overexpressed in human gliomas and enhances FGF-2 signaling in glioma cells. Am J Pathol (2006) 1.21
Chemical Tumor Biology of Heparan Sulfate Proteoglycans. Curr Chem Biol (2010) 1.17
Heparan sulfate sulfatase SULF2 regulates PDGFRα signaling and growth in human and mouse malignant glioma. J Clin Invest (2012) 1.12
Innate immune functions of microglia isolated from human glioma patients. J Transl Med (2006) 1.12
Differential expression of proteoglycans on the surface of human melanoma cells characterized by altered experimental metastatic potential. Am J Pathol (1992) 0.98
Angiogenic growth factors in neural embryogenesis and neoplasia. Am J Pathol (1995) 0.96
A novel adenoviral vector labeled with superparamagnetic iron oxide nanoparticles for real-time tracking of viral delivery. J Clin Neurosci (2012) 0.86
ApoE enhances nanodisk-mediated curcumin delivery to glioblastoma multiforme cells. Nanomedicine (Lond) (2013) 0.83
Novel therapeutic targets in the brain tumor microenvironment. Oncotarget (2012) 0.81
Genetic incorporation of the protein transduction domain of Tat into Ad5 fiber enhances gene transfer efficacy. Virol J (2007) 0.79
Prognostic significance of RSPO1, WNT1, P16, WT1, and SDC1 expressions in invasive ductal carcinoma of the breast. World J Surg Oncol (2013) 0.79
Altered expression of antithrombotic molecules in human glioma vessels. Acta Neuropathol (1994) 0.76
Role of Proteoglycans in Tumor Progression. Pathol Oncol Res (1995) 0.75
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet (1997) 15.38
The somatic genomic landscape of glioblastoma. Cell (2013) 11.73
Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J Clin Oncol (1999) 8.69
Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging (1999) 4.94
Temporal and rate representations of time-varying signals in the auditory cortex of awake primates. Nat Neurosci (2001) 3.62
U(L)31 and U(L)34 proteins of herpes simplex virus type 1 form a complex that accumulates at the nuclear rim and is required for envelopment of nucleocapsids. J Virol (2001) 3.56
MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res (1997) 3.38
Mesenteric and omental cysts: histologic classification with imaging correlation. Radiology (1987) 2.85
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo. Oncogene (2000) 2.81
The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res (1996) 2.76
Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3' untranslated region. Oncogene (2010) 2.73
The descriptive epidemiology of craniopharyngioma. J Neurosurg (1998) 2.66
Smokers' unrealistic optimism about their risk. Tob Control (2005) 2.60
Anterior transcranial (craniofacial) resection of tumors of the paranasal sinuses: surgical technique and results. Neurosurgery (1996) 2.30
Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994. Neuro Oncol (1999) 2.27
Aggressive meningeal tumors: review of a series. J Neurosurg (1995) 2.26
Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol (2000) 2.24
Aiolos regulates B cell activation and maturation to effector state. Immunity (1998) 2.24
Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas. J Clin Oncol (2000) 2.22
Osteoid osteoma. Radiographics (1991) 2.11
Gamma-radiation sensitivity and risk of glioma. J Natl Cancer Inst (2001) 2.06
Radiologic appearance of intramuscular hemangioma with emphasis on MR imaging. AJR Am J Roentgenol (1990) 2.00
Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol (1998) 2.00
Translational repressor bruno plays multiple roles in development and is widely conserved. Genes Dev (1997) 1.95
Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN. Cancer Res (1999) 1.95
Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling. Cancer Res (1999) 1.88
The biological monitoring of mercury in the Seychelles study. Neurotoxicology (1995) 1.82
The zig-zag volar-digital incision for flexor-tendon surgery. Plast Reconstr Surg (1967) 1.76
Human liver regeneration after major hepatectomy. A study of liver volume by computed tomography. Ann Surg (1991) 1.74
A homolog of voltage-gated Ca(2+) channels stimulated by depletion of secretory Ca(2+) in yeast. Mol Cell Biol (2000) 1.69
Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations. Cancer Res (2001) 1.68
Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis. Cancer Res (1999) 1.66
Cognitive function as a predictor of survival in patients with recurrent malignant glioma. J Clin Oncol (2000) 1.66
Osteosarcomatosis. Radiology (1990) 1.62
Mitotic recombination produces the majority of recessive fibroblast variants in heterozygous mice. Proc Natl Acad Sci U S A (1999) 1.61
Response and progression in recurrent malignant glioma. Neuro Oncol (1999) 1.57
Magnetic resonance appearance of peripheral nerve sheath tumors. Skeletal Radiol (1991) 1.54
Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis. Cancer Res (1998) 1.52
Expression of a multidrug resistance gene in esophageal adenocarcinoma. Correlation with response to chemotherapy and comparison with gastric adenocarcinoma. Am J Clin Pathol (1990) 1.50
The correlation of two argyrophilic nucleolar organizer region counting methods with bromodeoxyuridine-labeling index: a study of metastatic tumors of the brain. Hum Pathol (1993) 1.48
Outcome and patterns of failure following limited-volume irradiation for malignant astrocytomas. Radiother Oncol (1991) 1.47
Suppression of human glioma growth by adenovirus-mediated Rb gene transfer. Neurology (1998) 1.46
Fat-containing soft-tissue masses of the extremities. Radiographics (1991) 1.44
Isolation, karyotype, and clonal growth of heterogeneous subpopulations of human malignant gliomas. Cancer Res (1981) 1.44
Comparison of cell adhesion molecule expression between glioblastoma multiforme and autologous normal brain tissue. J Neuroimmunol (1995) 1.44
Prognostic study of gastric cancer without serosal invasion: reevaluation of the definition of early gastric cancer. J Am Coll Surg (1997) 1.42
Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme. Int J Radiat Oncol Biol Phys (1995) 1.41
Neural representations of temporally asymmetric stimuli in the auditory cortex of awake primates. J Neurophysiol (2001) 1.41
The autocrine loop of TGF-alpha/EGFR and brain tumors. J Neurooncol (1997) 1.40
Fibrous dysplasia. Radiographics (1990) 1.40
Pancreaticojejunal anastomotic leak after pancreaticoduodenectomy--multivariate analysis of perioperative risk factors. J Surg Res (1997) 1.39
Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas. Proc Natl Acad Sci U S A (1994) 1.39
Oxidative stress activates metal-responsive transcription factor-1 binding activity. Occupancy in vivo of metal response elements in the metallothionein-I gene promoter. J Biol Chem (1996) 1.37
The use of significant others as proxy raters of the quality of life of patients with brain cancer. Med Care (1997) 1.37
Surgical treatment of hepatolithiasis: long-term results. Surgery (1996) 1.36
Pyogenic liver abscesses in patients with malignant disease: a report of 52 cases treated at a single institution. Arch Surg (1998) 1.36
Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme. J Clin Oncol (2000) 1.35
A reappraisal of cholangiocarcinoma in patient with hepatolithiasis. Cancer (1993) 1.35
Imported case of MERS-CoV infection identified in China, May 2015: detection and lesson learned. Euro Surveill (2015) 1.32
Soft-tissue masses: diagnosis using MR imaging. AJR Am J Roentgenol (1989) 1.32
Obstructive jaundice secondary to ruptured hepatocellular carcinoma into the common bile duct. Surgical experiences of 20 cases. Cancer (1994) 1.32
Civil liability, criminal law, and other policies and alcohol-related motor vehicle fatalities in the United States: 1984-1995. Accid Anal Prev (2000) 1.31
Cartilaginous bone tumors. Radiol Clin North Am (1993) 1.30
Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme. Cancer Res (1994) 1.29
Smoking in the home and children's health. Tob Control (2008) 1.29
Giant cell tumor of the scapula. A review of 13 cases. Skeletal Radiol (1989) 1.28
Antiangiogenesis treatment for gliomas: transfer of antisense-vascular endothelial growth factor inhibits tumor growth in vivo. Cancer Res (1999) 1.28
Effect of disease burden on health-related quality of life in patients with malignant gliomas. Neuro Oncol (2000) 1.27
Hepatic resection in 120 patients with hepatocellular carcinoma. Arch Surg (1989) 1.27
Postoperative recurrence of hepatocellular carcinoma. Two hundred five consecutive patients who underwent hepatic resection in 15 years. Arch Surg (1994) 1.27
Dissemination and characterization of NDM-1-producing Acinetobacter pittii in an intensive care unit in China. Clin Microbiol Infect (2012) 1.26
Anti-malarial agent artesunate inhibits TNF-alpha-induced production of proinflammatory cytokines via inhibition of NF-kappaB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes. Rheumatology (Oxford) (2007) 1.23
Chromosome instability contributes to loss of heterozygosity in mice lacking p53. Proc Natl Acad Sci U S A (2000) 1.23
Maintenance of small bowel mucosa with glutamine-enriched parenteral nutrition. JPEN J Parenter Enteral Nutr (1990) 1.23
MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers. Oncogene (2011) 1.22
Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. Cancer Res (1996) 1.21
Reducing harmful alcohol-related behaviors: effective regulatory methods. J Stud Alcohol (2000) 1.21
Two tumor suppressive loci on chromosome 10 involved in human glioblastomas. Genes Chromosomes Cancer (1995) 1.21
Astrocytes derived from p53-deficient mice provide a multistep in vitro model for development of malignant gliomas. Mol Cell Biol (1995) 1.20
Health-related quality of life in patients with anaplastic astrocytoma during treatment with temozolomide. Eur J Cancer (2000) 1.19
Cerebral radiation necrosis following treatment of extracranial malignancies. Cancer (1984) 1.19
Inhibition of preadipocyte differentiation by myostatin treatment in 3T3-L1 cultures. Biochem Biophys Res Commun (2001) 1.19
Clinical experience in 20 hepatic resections for peripheral cholangiocarcinoma. Cancer (1989) 1.19
A reliability test of standard-based quantitative PCR: exogenous vs endogenous standards. Mol Cell Probes (2000) 1.18
Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo. Nat Med (1998) 1.18
Splenic hemangiomas and hamartomas: MR imaging characteristics of 28 lesions. Radiology (1997) 1.18
Expression and localization of urokinase-type plasminogen activator in human astrocytomas in vivo. Cancer Res (1994) 1.16
Hazards of electrical apparatus. Anesthesiology (1967) 1.16
Inhibition of herpes simplex virus replication by a 2-amino thiazole via interactions with the helicase component of the UL5-UL8-UL52 complex. J Virol (1998) 1.16
Analysis of the functional role of chromosome 10 loss in human glioblastomas. Cancer Res (1993) 1.15
Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings. Am J Gastroenterol (2000) 1.15
Identification and characterization of a melanin-concentrating hormone receptor. Proc Natl Acad Sci U S A (2001) 1.14
Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN. Oncogene (2001) 1.14
Expression and localization of urokinase-type plasminogen activator receptor in human gliomas. Cancer Res (1994) 1.13
Enhancement of CD8+ T cell responses by ICOS/B7h costimulation. J Immunol (2001) 1.13